Item 2.02 Results of Operations and Financial Condition.
On
The financial results included in the corporate presentation are unaudited and
preliminary estimates that (i) represent the most current information available
to management as of the date of this Current Report on Form 8-K, (ii) are
subject to completion of financial closing and procedures that could result in
significant changes to the estimated amounts, and (iii) do not present all
information necessary for an understanding of the Company's financial condition
as of and its results of operations for the year ended
In accordance with General Instruction B.2. of Form 8-K, the information in this Item 2.02 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Company's filings under the Securities Act of 1933, as amended (the "Securities Act"), whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.
Item 7.01 Regulation FD Disclosure.
On
The information in Item 7.01 of this Current Report on Form 8-K (including Exhibits 99.1 and 99.2 attached hereto) are being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference into any filing by the Company, under the Securities Act, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 8.01 Other Events.
On
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
No. Description of ExhibitTheseus Pharmaceuticals, Inc. Corporate Presentation, datedJanuary 5 , 99.1 2023 Press release issued byTheseus Pharmaceuticals, Inc. onJanuary 5 , 99.2 2023 Cover Page Interactive Data File (embedded within the Inline XBRL 104 document)
© Edgar Online, source